English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduDr. Salma Jabbour has been named a Fellow of the American Society of Radiation Oncology (FASTRO). This distinction honors individuals who have made significant contributions to the society and to the field of radiation oncology through research, education, patient care and service to the field.
Tag: New Brunswick
Protecting your Heart Before, During and After Cancer Treatment
Therapies such as chemotherapy, radiotherapy, immunotherapy and other novel targeted treatments that are used to combat many cancers have the potential to contribute to cardiac toxicity. Rutgers Cancer Institute expert sheds light on the field of Cardo-Oncology, which focuses on the prevention and treatment of cardiac-related issues in cancer patients.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Leader Recognized as NJBIZ 2021 Healthcare Hero
Rutgers Cancer Institute of New Jersey Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences, has been named by the business journal NJBIZ as a 2021 Healthcare Hero in the healthcare professional category.
What is Bladder Cancer?
The bladder, a part of the urinary system, is a hollow organ in the pelvis with the primary function of storing and then eliminating urine that drains into it from the kidney. Cancer of the bladder develops when abnormal cells in the bladder start to grow out of control. Rutgers Cancer Institute expert explains what you need to know.
Exploring Amino Acids Signaling as Intervention for Diabetes and Pancreatic Cancers
Researchers from Rutgers Cancer Institute of New Jersey previously identified a small protein called Rab1A that regulates amino acid signaling. In a recent study, researchers explored the physiological role of Rab1A in mammals using mice though a technique in which one of an organism’s genes is made inoperative, known as genetic knockout.
Negligible Detection of SARS-CoV2 found in Environmental Surface Testing of Hematology/Oncology Inpatient and Outpatient Settings
Researchers from Rutgers Cancer Institute of New Jersey evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study, published in Cancer, revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.
Gallbladder and Bile Ducts: Small Organs with Big Responsibilities
Gallbladder cancer and bile duct cancers are rare, which is why it is important to learn the signs and symptoms of these diseases and help spread awareness. Rutgers Cancer Institute expert highlights these types of cancers for Gallbladder and Bile duct cancer awareness month.
Gynecologic Oncology Leader Named at New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital (RWJUH), a RWJBarnabas Health facility, have named James K. Aikins, Jr., MD, FACOG, FACS chief of gynecologic oncology at Rutgers Cancer Institute and chief of gynecologic oncology services at RWJUH, New Jersey’s largest academic medical center.
First Patient Recently Treated with New Non-Surgical Therapy for Urothelial Cancer at Rutgers Cancer Institute
Upper tract urothelial cancer (UTUC) is a subset of urothelial cancer that is found in the renal pelvis or the ureter, part of the genitourinary tract. Surgery has remained the mainstay of treatment for this type of cancer, until last year, when the U.S. Food and Drug Administration (FDA) approved mitomycin gel as the first non-surgical therapy option to treat this type of cancer. Rutgers Cancer Institute of New Jersey has recently treated its first UTUC patient with this new therapy.
Research Leader Named to Rutgers Cancer Institute from National Cancer Institute to Build World-Class Cancer Immunology and Immunotherapy Programs
Research Leader Christian Hinrichs, MD, has been named Chief of the Section of Cancer Immunotherapy and Co-Director of the Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute of New Jersey,
Make your Health a Priority in 2021
Rutgers Cancer Institute Expert shares ways to start fresh in 2021 by making resolutions that prioritize a healthy lifestyle and help prevent cancer and other chronic conditions.
Rutgers Cancer Institute of New Jersey Receives $25 Million Gift for Cancer Immunology and Metabolism Center of Excellence
A $25 million transformational gift given to Rutgers Cancer Institute will provide critical support for the Cancer Immunology and Metabolism Center of Excellence to help scientists better understand the human immune response to cancer and ultimately develop the foundation for new treatments or make existing therapies more effective.
Safely Donate Blood This Winter
With the added concern of COVID-19 safety, there will be drop in the donation of critically needed blood throughout the United States, which is typically low during the winter months. Expert from Rutgers Cancer Institute of New Jersey urges giving the gift of life by donating blood.
Environmental Surface Testing in Inpatient and Outpatient Hematology/Oncology Settings Shows Negligible Detection of SARS-CoV2
Researchers from Rutgers Cancer Institute of New Jersey evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.
Exploring the Role of Tumor Suppressor Enhancers in the Development of T-cell Acute Lymphoblastic Leukemia
Researchers from Rutgers Cancer Institute of New Jersey identified a novel enhancer that interacts with a tumor suppressor gene and explored its involvement in normal T-cell development as well as in T-cell acute lymphoblastic leukemia (T-ALL).
Rutgers Expert Available to Discuss Record November Heat in New Jersey
New Brunswick, N.J. (Nov. 10, 2020) – Rutgers University–New Brunswick climatologist David A. Robinson is available for interviews on the recent record heat in New Jersey, including four consecutive days of record high temperatures in New Brunswick. “Today marks the sixth consecutive day…
Exploring Autophagy as a Therapeutic Strategy against Frequent Mutations in Non-Small Cell Lung Cancer
Rutgers Cancer Institute of New Jersey expert investigates the role of a cellular survival mechanism known as autophagy in the formation of tumors driven by mutations in tumor suppressors known as LKB1 and oncogene KRAS.
Tackling Breast Cancer with Screening and Prevention
While researchers continue to make advances in breast cancer detection and treatment, one of the best ways to tackle the disease is through early detection and screening. Rutgers Cancer Institute expert shares more about risk factors, warning signs, and screening.
Surgery Milestone Reached for Rutgers Cancer Institute Urologic Oncology Leader at Robert Wood Johnson University Hospital
Rutgers Cancer Institute of New Jersey Urologic Oncology chief marks a major milestone in completing his 2,000th robotic prostatectomy at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility and one of the few hospitals in the state designated to teach surgeons about this technique.
Rutgers Expert Available to Discuss How Hip-Hop Music Gives Voice to Populations Left Out of the Political Discourse
FOR IMMEDIATE RELEASE Media contact: Cynthia Medina, [email protected], 848-445-1940 Rutgers Expert Available to Discuss How Hip-Hop Music Gives Voice to Populations Left Out of the Political Discourse New Brunswick, N.J. (Jan. 30, 2020) – Rutgers scholar Derrick Darby, an…
High Levels of Fecal Bacteria Found in Lower Raritan River
New Brunswick, N.J. (Sept. 17, 2019) – High levels of fecal bacteria have often been found at six new water sampling sites in the lower Raritan River since May, according to a Rutgers-coordinated monitoring program that included more than 20…